Published on in Vol 11, No 10 (2022): October
1 Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology, IRCCS, Milan, Italy
2 Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy
3 Department of Public Health and Primary Care, Centre for Biomedical Ethics and Law, KU Leuven, Leuven, Belgium
4 Paul Baerwald School of Social Work and Social Welfare, The Hebrew University of Jerusalem, Jerusalem, Israel
5 Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Lisboa, Portugal
6 Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan, Italy
7 Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy
8 Department of Oncology, Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
9 Department of Communication Disorders, The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
10 Champalimaud Research and Clinical Centre, Champalimaud Foundation, Lisboa, Portugal
11 ISPA, Instituto Universitário, Lisboa, Portugal
12 NOVA Medical School, NMS, Universidade Nova de Lisboa, Lisboa, Portugal
13 In Silico Oncology and In Silico Medicine Group, Institute of Communication and Computer Systems, Athens, Greece
14 School of Electrical and Computer Engineering, Athens, Greece
15 National Technical University of Athens, Athens, Greece
16 Nordic Healthcare Group, Helsinki, Finland
17 Varian Medical System, Helsinki, Finland
18 Department of Psychology, University of Crete, Crete, Greece
19 Foundation for Research and Technology - Hellas, Heraklion, Greece